Autoimmunity in viral myocarditis
Abstract
Purpose of review To review how autoimmunity is induced in viral myocarditis. Recent findings Clinical and experimental myocarditis follows microbial infections, but autoimmunity to cardiac antigens leads to heart failure since infected myocytes are sparse and virus clearance is rapid. In mice, CD4+ T cells specific for cardiac alpha myosin heavy chain (αMYHC) cause myocarditis and mice tolerized to αMYHC are protected from virus challenge proving pathogenesis depends upon autoimmunity. Most importantly, multiple microbes share the same mimicking epitope with αMYHC. Serial infections with very different microbes could result in memory responses to the shared epitope leading to aggressive and severe heart failure. A similar phenomenon may explain autoimmune diseases with suspected infectious causes, where specific pathogens have not been identified. Production of the relevant cardiac epitope for antigen presentation requires more than myosin release from dead myocytes. Otherwise, myocarditis would commonly follow myocardial infarcts. The inherent nature of the innate immune response associated with viral infections in the heart is crucial to cardiac epitope expression. Summary Antigenic mimicry between microbes and cardiac proteins causes autoimmunity in myocarditis. Characteristics of innate immunity associated with cardiac infection determine relevant epitope expression (cryptic epitopes).
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Autoantibodies targeting heart antigens are present in patients with viral myocarditis.
“numerous clinical studies have reported the presence of autoantibodies targeting heart antigens in patients with viral myocarditis”
From Autoimmune Myocarditis, Old Dogs and New Tricks. (2024) · cites this paper as [14]
Cites
Sagar, S., Liu, P. P., & Cooper, L. T. (2012) · The Lancet · doi:10.1016/s0140-6736(11)60648-x · Cited by 743 · see citing works
PD-1 Protects against Inflammation and Myocyte Damage in T Cell-Mediated Myocarditis
Tarrio, M. L., Grabie, N., Bu, D.-X., Sharpe, A. H., & Lichtman, A. H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200389 · Cited by 288 · see citing works
Frisancho-Kiss, S., Davis, S. E., Nyland, J. F., Frisancho, J. A., Cihakova, D., Barrett, M. A., Rose, N. R., & Fairweather, D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.11.6710 · Cited by 212 · see citing works
Update on coxsackievirus B3 myocarditis
Fairweather, D., Stafford, K. A., & Sung, Y. K. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328353372d · Cited by 165 · see citing works
Abston, E. D., Coronado, M. J., Bucek, A., Bedja, D., Shin, J., Kim, J. B., Kim, E., Gabrielson, K. L., Georgakopoulos, D., Mitzner, W., et al. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/129486 · Cited by 94 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Immune checkpoint inhibitor–associated myocarditis: manifestations and mechanisms
Moslehi, J., Lichtman, A. H., Sharpe, A. H., Galluzzi, L., & Kitsis, R. N. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145186 · Cited by 237 · see citing works
Autoimmune Myocarditis, Old Dogs and New Tricks.
Won, T., Song, E. J., Kalinoski, H. M., Moslehi, J. J., & Čiháková, D. (2024) · Circulation Research · doi:10.1161/circresaha.124.323816 · Cited by 51 · see citing works
- Authors
- Reddy, J., Massilamany, C., Buskiewicz, I., & Huber, S. A.
- Affiliations
- University of Nebraska–Lincoln (US)
- University of Vermont (US)
- Corresponding author
- Huber, Sally A.
- Venue
- Current Opinion in Rheumatology
- Published
- 2013-07
- Volume
- 25
- Issue
- 4
- Pages
- 502-508
- ISSN
- 1040-8711 (ISSN-L)
- OpenAlex
- W2041277567
- Cited by
- 50
- References
- 5
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 3 · 2021: 9 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 4 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 2
- FWCI
- 0.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Rheumatology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Public Health Service (09SDG2010237)
- National Heart, Lung, and Blood Institute (HL108371, R01HL108371)
- National Institute of General Medical Sciences (P20GM103496)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- viral myocarditis, autoimmunity, molecular mimicry, CD4+ T cells, heart failure, shared epitope, cryptic epitopes, innate immunity, myocardial infarction
- MeSH terms
- Animals, Autoantigens, Autoimmune Diseases, Autophagy, Humans, Immunity, Innate, Myocarditis, Virus Diseases, Autoimmunity, Molecular Mimicry, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review